Hundreds of cancer patients from all over the world travel annually to the Caribbean Island of Cuba to obtain the ESCOZUL treatment. Many people have been healed with the ESCOZUL or at least their life quality has improved considerably although, until the moment, there is no scientific publication that endorses the anti-carcinogenic properties of the ESCOZUL. It is well known that the Cuban government is developing scientific researchers to demonstrate the ESCOZUL properties. The research has been developed in LABIOFAM (Havana, Cuba). But the cancer patients cannot wait for the end of the clinical trials and they decide to try with the ESCOZUL.
ESCOZUL is an alternative cancer treatment based on the blue scorpion venom. My wife who has breast cancer has been taking it for 4 months and the results are extremely positive, the tumor is stopped.
The ESCOZUL is a natural solution obtained from the venom of the blue scorpion Rhopalurus junceus. The blue scorpion exclusively inhabits Cuba and the properties of its venom were discovered more than 20 years ago.
The truth is that the ESCOZUL is healing cancer patients without side effects. The clinical trials undertaken in LABIOFAM are in phase 3. The ESCOZUL has shown very promised results in laboratory mice. Actually, LABIOFAM has more than 2000 people who have been taking ESCOZUL for more than 4 years and they have survived cancer. But, at the same time, there is a lot of misinformation and manipulation around the ESCOZUL treatment on Internet.
After reading all the information we could about the ESCOZUL, I have found this website where it is explicit explained the truth about the ESCOZUL. I strongly advice all the cancer patients to carefully read what it is said about this on our website. Later you can choose to try or not the ESCOZUL as an alternative cancer treatment
The second cause of death in Cuba is CANCER is, with approximately 18,900 deaths and 28,100 new cases per year.
In conjunction with Brazil, a South American giant in the sector, Cuba has cooperation programs for the production of medicaments which, without reducing their quality, are sold for less cost in world markets than those of the large international pharmaceutical industry.
National estimates confirm that the incidence of this disease in a country of 11 million inhabitants is on the rise due to phenomena such as addiction to tobacco and alcohol.
Cuba has developed a broad and successful biotechnological sector which, to a large extent, has directed research over the years to obtaining therapeutic vaccines and various treatments to combat the disease.
Aspects of Cuban scientific development include expanding the national production of oncological medicaments: cytostatics, support medicines and new biotechnological products.
National studies indicate that, on the basis of its anti-cancer medicaments and programs, Cuba has the potential of averting more than 10,000 new cases every year. Prevention campaigns play a significant role in reaching this objective.
Calls to quit smoking and limit alcohol consumption have been linked for a number of years to medical proposals for life style changes which can alleviate the incidence of malign tumors of the prostrate and colon.
But Cuba’s greatest hopes in combating cancer lie in its biotechnology industry, which has an excellent reputation in the world.
Last week this sector established agreements with China for the joint development of vaccines and other biotechnological products, which include bilateral action in relation to prevention, early diagnosis and the control of cancer.